Skip to Content

A/P 25/15 (Alogliptin Benzoate and Pioglitazone Hydrochloride 25 mg / 15 mg)

Pill with imprint A/P 25/15 is Yellow, Round and has been identified as Alogliptin benzoate and pioglitazone hydrochloride 25 mg / 15 mg. It is supplied by Perrigo New York Inc..

Alogliptin/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Alogliptin/pioglitazone 25 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A/P 25/15

Alogliptin benzoate and pioglitazone hydrochloride

A/P 25/15
25 mg / 15 mg
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Perrigo New York Inc.
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.